Profile data is unavailable for this security.
About the company
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
- Revenue in EUR (TTM)5.53m
- Net income in EUR-53.35m
- Incorporated2008
- Employees162.00
- LocationCarmat SA36avenue de l'Europe, Immeuble l'EtendardVELIZY VILLACOUBLAY 78140FranceFRA
- Phone+33 139456450
- Fax+33 139456451
- Websitehttps://www.carmatsa.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modulight Oyj | 3.45m | -11.85m | 41.98m | 79.00 | -- | 0.8078 | -- | 12.17 | -0.2844 | -0.2844 | 0.0836 | 1.22 | 0.0516 | -0.3111 | 1.94 | 49,271.43 | -17.72 | -8.39 | -18.97 | -9.10 | 123.49 | 114.69 | -343.58 | -56.81 | 4.50 | -- | 0.0965 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| MeVis Medical Solutions AG | 17.64m | 5.75m | 44.04m | 111.00 | 7.66 | 2.47 | 7.51 | 2.50 | 3.16 | 3.16 | 9.69 | 9.79 | 0.7128 | -- | 7.95 | 174,693.80 | 23.24 | 22.74 | 28.00 | 29.85 | 97.24 | 96.90 | 32.60 | 35.45 | -- | -- | 0.00 | 27.86 | -7.57 | -0.4922 | -36.84 | -8.38 | -17.46 | 0.00 |
| Substrate Artificial Inteligence SA | 13.70m | -6.09m | 44.25m | 17.00 | -- | 0.3683 | -- | 3.23 | -0.2262 | -0.2262 | 0.2148 | 0.2878 | 0.3905 | 0.2868 | 6.52 | 806,132.90 | -15.79 | -- | -20.57 | -- | 97.35 | -- | -40.44 | -- | 0.591 | -12.93 | 0.141 | -- | 174.53 | -- | 42.10 | -- | -- | -- |
| AbL Diagnostics SA | 5.61m | 54.36k | 45.77m | 19.00 | 842.73 | 6.76 | 63.87 | 8.15 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
| Medicalgorithmics SA | 8.03m | -2.33m | 49.73m | 120.00 | -- | 2.60 | -- | 6.19 | -1.02 | -1.02 | 3.52 | 8.39 | 0.3048 | 0.6718 | 8.57 | 291,900.00 | -8.85 | -0.9441 | -9.71 | -1.18 | 80.08 | 89.46 | -29.05 | -2.19 | 1.65 | -- | 0.0513 | 0.00 | -31.28 | -26.39 | -102.27 | -- | -18.81 | -- |
| Omda AS | 35.50m | 7.70m | 51.56m | 295.00 | 6.67 | 10.41 | 3.97 | 1.45 | 4.35 | 4.35 | 20.60 | 2.79 | 0.5886 | 238.36 | 10.38 | 1,434,162.00 | 13.80 | -4.92 | 18.03 | -6.37 | 92.89 | 90.22 | 23.45 | -9.83 | 1.14 | 2.56 | 0.8946 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| OssDsign AB | 10.68m | -9.85m | 53.16m | 27.00 | -- | 2.73 | -- | 4.98 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Tissue Regenix Group PLC | 29.84m | -1.03m | 53.68m | 76.00 | -- | 1.90 | 1,505.14 | 1.80 | -0.0121 | -0.0121 | 0.3503 | 0.3269 | 0.7061 | 1.33 | 6.41 | 325,107.60 | -2.17 | -13.45 | -2.43 | -14.78 | 49.48 | 45.90 | -3.08 | -28.80 | 1.47 | 0.3716 | 0.263 | -- | 20.50 | 13.75 | 36.44 | -- | 9.78 | -- |
| Gentian Diagnostics ASA | 12.50m | 188.81k | 54.04m | 58.00 | 326.39 | 3.94 | 56.01 | 4.32 | 0.1262 | 0.1262 | 9.35 | 10.47 | 0.7792 | 1.69 | 8.40 | 2,533,190.00 | 1.18 | -10.76 | 1.33 | -11.86 | 51.69 | 41.46 | 1.51 | -26.99 | 5.01 | -- | 0.0394 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| Mentice AB | 24.30m | -882.96k | 55.32m | 134.00 | -- | 4.19 | 38.65 | 2.28 | -0.3998 | -0.3998 | 10.95 | 5.97 | 0.9046 | 3.05 | 3.28 | 2,301,221.00 | -3.29 | -7.69 | -6.32 | -13.07 | 85.36 | 83.67 | -3.63 | -10.00 | 1.00 | -- | 0.0382 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Carmat SA | 5.53m | -53.35m | 57.67m | 162.00 | -- | -- | -- | 10.43 | -1.76 | -1.76 | 0.1787 | -0.6419 | 0.0932 | 1.61 | 1.28 | 30,379.12 | -89.92 | -76.92 | -113.71 | -94.38 | -535.50 | -- | -964.91 | -4,636.64 | 1.69 | -17.37 | 1.63 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
| Senzime AB (publ) | 4.79m | -11.38m | 61.30m | 52.00 | -- | 2.62 | -- | 12.81 | -1.09 | -1.09 | 0.4595 | 2.38 | 0.1533 | 1.57 | 4.91 | -- | -36.44 | -35.69 | -39.12 | -38.00 | 33.27 | -20.59 | -237.75 | -558.68 | 2.62 | -- | 0.0739 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Oncosem Onkolojik Sistemlr Sny v Tcrt AS | 8.50m | -3.65m | 64.24m | 249.00 | -- | 10.04 | -- | 7.56 | -5.70 | -5.70 | 13.12 | 9.81 | 1.02 | 3.66 | 4.56 | 959,448.30 | -43.70 | -- | -61.60 | -- | 21.29 | -- | -43.01 | -- | 1.10 | -5.21 | 0.2552 | -- | -17.90 | -- | -284.37 | -- | -- | -- |
| ADDvise Group AB (publ) | 140.74m | 9.90m | 68.82m | 643.00 | 20.89 | 3.15 | 3.78 | 0.489 | 0.5935 | 0.5935 | 8.38 | 3.93 | 0.565 | 8.37 | 5.77 | 2,606,250.00 | 3.98 | 3.72 | 4.82 | 4.77 | 42.07 | 48.95 | 7.04 | 5.89 | 1.40 | 2.35 | 0.6969 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Affluent Medical SAS | 0.00 | -17.04m | 70.02m | 66.00 | -- | 2.26 | -- | -- | -0.5338 | -0.5338 | 0.00 | 0.7864 | 0.00 | -- | -- | 0.00 | -28.43 | -- | -34.69 | -- | -- | -- | -- | -- | -- | -24.62 | 0.3586 | -- | -- | -- | -2.80 | -- | -- | -- |
| Fonet Bilgi Teknolojileri AS | 10.74m | 5.16m | 72.81m | 498.00 | 6.16 | 2.93 | 8.40 | 6.78 | 3.00 | 3.00 | 3.32 | 6.32 | 0.5937 | 375.46 | 3.92 | 898,996.60 | 28.55 | 15.85 | 32.44 | 18.16 | 27.24 | 35.84 | 48.10 | 36.80 | 1.72 | -- | 0.0062 | 0.00 | 5.36 | 47.56 | 520.64 | 64.79 | 49.71 | -- |
Data as of Nov 12 2024. Currency figures normalised to Carmat SA's reporting currency: Euro EUR
1.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OFI Invest Asset Management SAas of 29 Aug 2024 | 260.00k | 0.72% |
| La Fran�aise Asset Management SASas of 31 Jul 2024 | 190.00k | 0.53% |
| Apo Asset Management GmbHas of 30 Sep 2023 | 66.00k | 0.18% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 0.00 | 0.00% |
More ▼
Data from 30 Apr 2024 - 30 Oct 2024Source: FactSet Research Systems Inc.
